Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02360644 · ClinicalTrials.gov registry record · NA

Drug Metabolizing Enzyme and Transporter Function in Chronic Kidney Disease

A NA study, sponsored by University of Colorado, Denver.

Completed
Registry status
NA
Development phase
23
Enrollment target

NCT02360644 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 23 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02360644, a NA study, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
NA
Development phase
23 participants
Enrollment target

Study Summary

This study investigates the effect of vitamin D deficiency on drug metabolism and transport in patients with chronic kidney disease (CKD) and in healthy controls. The central hypothesis is that vitamin D concentrations independently affect metabolism and transport function in CKD patients. An over-arching goal of this proposal is to make drug therapies safer and more effective to reduce the significant morbidity and mortality in patients with CKD.

Interventions

  • DIETARY_SUPPLEMENT Cholecalciferol

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2014-10
Est. Completion 2019-02-01
Phase NA

Sponsor

University of Colorado, Denver

1,283 total trials

What the Registry Record Tells You About NCT02360644

The ClinicalTrials.gov registry entry for NCT02360644 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Cholecalciferol is the first listed.

NCT02360644 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02360644 about?

NCT02360644 is a clinical study titled "Drug Metabolizing Enzyme and Transporter Function in Chronic Kidney Disease". This study investigates the effect of vitamin D deficiency on drug metabolism and transport in patients with chronic kidney disease (CKD) and in healthy controls. The central hypothesis is that vitamin D concentrations independently affect metabolism and transport function in CKD patients. An over-...

What is the current status of trial NCT02360644?

This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2014-10. Estimated completion is 2019-02-01.

What interventions are being tested in trial NCT02360644?

The interventions under investigation include: Cholecalciferol (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT02360644?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.